<DOC>
	<DOCNO>NCT01442402</DOCNO>
	<brief_summary>Aim 1 : Determine association APOL1 risk variant allograft survival function African Americans Aim 2 : Determine association presence APOL1 risk variant African American kidney transplant recipient risk recurrent disease Aim 3 : Investigate mechanism APOL1 associate kidney disease prospectively follow African American kidney transplant recipient throughout clinical course .</brief_summary>
	<brief_title>APOL1 Gene Variants African American Kidney Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>Aim 1 : selfreported African American 18 year old kidney transplant within 12 year Aim 2 : Inclusion Criteria patient recurrent disease : selfreported African American 18 year old kidney transplant within 12 year recurrent de novo glomerular disease allograft kidney biopsy Inclusion Criteria control group : selfreported African American 18 year old kidney transplant within 12 year end stage kidney disease due glomerular nephritis , clinically diagnose native kidney biopsy Exclusion Criteria control group : clinical evidence recurrent disease ( presence proteinuria , hematuria , Creatinine &gt; 2 ) Aim 3 : selfreported African American 18 year old schedule live kidney transplant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>